deltatrials
Completed NA INTERVENTIONAL 2-arm NCT03793907

Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma

Feasibility of Strength Training and Impact on Pain and Quality of Life in Patients With Multiple Myeloma

Sponsor: Roswell Park Cancer Institute

Conditions Plasma Cell Myeloma
Interventions FitBit Quality-of-Life Assessment Questionnaire Administration Resistance Training STEPS to Enhance Physical Activity
Updated 18 times since 2019 Last updated: Apr 7, 2023 Started: Dec 17, 2019 Primary completion: Feb 28, 2022 Completion: Nov 10, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03793907, this NA trial focuses on Plasma Cell Myeloma and remains completed. Sponsored by Roswell Park Cancer Institute, it has been updated 18 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~May 2019 · 2 months · monthly snapshot~May 2019 – ~Jul 2019 · 2 months · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Apr 2020 · 6 months · monthly snapshot~Apr 2020 – ~Jun 2020 · 2 months · monthly snapshot~Jun 2020 – ~Aug 2020 · 2 months · monthly snapshot~Aug 2020 – ~Oct 2020 · 2 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Sep 2022 · 8 months · monthly snapshot~Sep 2022 – ~May 2023 · 8 months · monthly snapshot~May 2023 – ~Jul 2024 · 14 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. May 2023 — Jul 2024 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  4. Sep 2022 — May 2023 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  5. Jan 2022 — Sep 2022 [monthly]

    Recruiting NA

▶ Show 13 earlier versions

  1. Dec 2021 — Jan 2022 [monthly]

    Recruiting NA

  2. Oct 2021 — Dec 2021 [monthly]

    Recruiting NA

  3. Jan 2021 — Oct 2021 [monthly]

    Recruiting NA

  4. Oct 2020 — Jan 2021 [monthly]

    Recruiting NA

  5. Aug 2020 — Oct 2020 [monthly]

    Recruiting NA

  6. Jun 2020 — Aug 2020 [monthly]

    Recruiting NA

  7. Apr 2020 — Jun 2020 [monthly]

    Recruiting NA

  8. Oct 2019 — Apr 2020 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  9. Aug 2019 — Oct 2019 [monthly]

    Not Yet Recruiting NA

  10. Jul 2019 — Aug 2019 [monthly]

    Not Yet Recruiting NA

  11. May 2019 — Jul 2019 [monthly]

    Not Yet Recruiting NA

  12. Mar 2019 — May 2019 [monthly]

    Not Yet Recruiting NA

  13. Feb 2019 — Mar 2019 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Roswell Park Cancer Institute
Data source: Roswell Park Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations